Phase II evaluation of Dasatinib in the treatment of recurrent or persistent epithelial ovarian or primary peritoneal carcinoma: A Gynecologic Oncology Group study

OBJECTIVE: Preclinical data suggest an important role for the sarcoma proto-oncogene tyrosine kinase (SRC) in the oncogenesis of epithelial ovarian cancer (EOC) or primary peritoneal carcinoma (PPC). The Gynecologic Oncology Group (GOG) conducted a Phase II trial to evaluate the efficacy and safety...

Celý popis

Uloženo v:
Podrobná bibliografie
Hlavní autoři: Schilder, Russell J., Brady, William E., Lankes, Heather A., Fiorica, James V., Shahin, Mark S., Zhou, Xun C., Mannel, Robert S., Pathak, Harsh B., Hu, Wei, Alpaugh, R. Katherine, Sood, Anil K., Godwin, Andrew K.
Médium: Artigo
Jazyk:Inglês
Vydáno: 2012
Témata:
Article
On-line přístup:https://ncbi.nlm.nih.gov/pmc/articles/PMC3748717/
https://ncbi.nlm.nih.gov/pubmed/22710075
https://ncbi.nlm.nih.govhttp://dx.doi.org/10.1016/j.ygyno.2012.06.009
Tagy: Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!

Podobné jednotky